Literature DB >> 25099155

HLA-C*12:02 is a susceptibility factor in late-onset type of psoriasis in Japanese.

Tomotaka Mabuchi1, Tami Ota, Yasuaki Manabe, Norihiro Ikoma, Akira Ozawa, Tadashi Terui, Shigaku Ikeda, Hidetoshi Inoko, Akira Oka.   

Abstract

Psoriasis is thought to be a multifactorial disease triggered by both genetic and environmental factors. The HLA-C locus on chromosome 6p21.33 remains the strongest susceptibility candidate locus in psoriasis. The strong association between psoriasis and the HLA-Cw6 allele has been well documented in various races. It is known that psoriatic patients with early onset are more likely to be familial and associated with HLA-Cw6. Familial occurrence of Japanese psoriasis is smaller than other populations. Furthermore, males are predominant over females in Japanese psoriasis. We investigated the relation between HLA-C alleles and age of onset, and in each gender for Japanese psoriasis, and discuss male predominance in the incidence of psoriasis in Japan. Four hundred forty six unrelated Japanese patients with psoriasis vulgaris and 557 sex- and age-matched unrelated Japanese healthy controls were investigated by genotyping. We confirmed the association between early-onset type of psoriasis with HLA-C*06:02 allele in Japanese. In addition, we detected the association between the late-onset type of psoriasis and the HLA-C*12:02 allele in Japanese. No significant differences in allele frequency were observed between females and males. Our results suggest that there is no genetic factor effect on male predominance in Japanese. In contract, the effect of environmental risk factors on the onset of Japanese psoriatic patients is stronger in males than in females. As a result, male predominant in psoriasis may occur in Japan.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  HLA-Cw6; early onset; male predominance; male-to-female ratio; psoriasis

Mesh:

Substances:

Year:  2014        PMID: 25099155     DOI: 10.1111/1346-8138.12569

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  15 in total

1.  Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis.

Authors:  Laura C Cappelli; Mehmet T Dorak; Maria P Bettinotti; Clifton O Bingham; Ami A Shah
Journal:  Rheumatology (Oxford)       Date:  2019-03-01       Impact factor: 7.580

2.  Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Authors:  Yang Lo; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

3.  Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Authors:  Marina Talamonti; Giovanna Malara; Ylenia Natalini; Federico Bardazzi; Andrea Conti; Andrea Chiricozzi; Cristina Mugheddu; Paolo Gisondi; Stefano Piaserico; Gianluca Pagnanelli; Paolo Amerio; Concetta Potenza; Franca Cantoresi; Maria Concetta Fargnoli; Anna Balato; Francesco Loconsole; Annamaria Offidani; Claudio Bonifati; Francesca Prignano; Marta Bartezaghi; Alice Rausa; Elisabetta Aloisi; Roberto Orsenigo; Antonio Costanzo
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

4.  Correlation Between HLA-A, B and DRB1 Alleles and Severe Fever with Thrombocytopenia Syndrome.

Authors:  Shu-Jun Ding; Yi Zhang; Xiao-Mei Zhang; Xiao-Lin Jiang; Bo Pang; Yong-Hong Song; Jian-Xing Wang; Yao-Wen Pei; Chuan-Fu Zhu; Xian-Jun Wang; Xue-Jie Yu
Journal:  PLoS Negl Trop Dis       Date:  2016-10-19

5.  The HLA-Cw12 Allele Is an Important Susceptibility Allele for Psoriasis and Is Associated with Resistant Psoriasis in the Turkish Population.

Authors:  Nahide Onsun; Serpil Pirmit; Dilek Ozkaya; Şirin Çelik; Aylin Rezvani; F Pelin Cengiz; Cigdem Kekik
Journal:  ScientificWorldJournal       Date:  2019-06-25

6.  A Large-Scale, Stratified Genetic Analysis of the Major Histocompatibility Complex Region in Early- and Late-Onset Psoriasis in China.

Authors:  Yi Zhou; Minglong Cai; Yujun Sheng; Xuejun Zhang
Journal:  Ann Dermatol       Date:  2020-12-30       Impact factor: 1.444

7.  Polymorphisms Associated with Age at Onset in Patients with Moderate-to-Severe Plaque Psoriasis.

Authors:  Rocío Prieto-Pérez; Guillermo Solano-López; Teresa Cabaleiro; Manuel Román; Dolores Ochoa; María Talegón; Ofelia Baniandrés; José Luis López-Estebaranz; Pablo de la Cueva; Esteban Daudén; Francisco Abad-Santos
Journal:  J Immunol Res       Date:  2015-11-03       Impact factor: 4.818

Review 8.  Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.

Authors:  Masutaka Furue; Gaku Tsuji; Takahito Chiba; Takafumi Kadono
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

9.  Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis.

Authors:  Florian Anzengruber; Adhideb Ghosh; Julia-Tatjana Maul; Mathias Drach; Alexander A Navarini
Journal:  Psoriasis (Auckl)       Date:  2018-03-23

Review 10.  Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis.

Authors:  Jörg Christoph Prinz
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.